Medication info
Omethan Tablet 20 mg (Olmesartan Medoxomil)

Omethan Tablet 20 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100866 · Approved 2011.02.22 · Insurance code 650302740

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while monitoring the patient's condition closely. <Elderly patients> No dose adjustment is required when administering this drug to elderly patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
Child dose
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension, which is a representative form of high blood pressure.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while monitoring the patient's condition closely. <Elderly patients> No dose adjustment is required when administering this drug to elderly patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.

Child dose

<Pediatric patients> The safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any of the ingredients in this medication, those receiving kidney dialysis, patients with severe liver impairment, those with biliary obstruction, and patients with lactose intolerance should not use this medication. Patients with reduced blood volume or low sodium may experience a sudden drop in blood pressure when starting this medication, so caution is necessary. Patients with weak kidney function should have regular check-ups of their kidney function and blood potassium levels. This medication is used for the treatment of high blood pressure and may cause side effects such as dizziness, headaches, abdominal pain, and muscle pain; however, these are generally mild and temporary. Prolonged use may lead to chronic diarrhea or intestinal dysfunction, so if symptoms persist, consultation with a doctor is necessary. Care should be taken when used in combination with other antihypertensive agents or potassium-sparing diuretics as there is a risk of elevated blood potassium levels. During pregnancy, this medication should not be taken as it can affect fetal kidney development, and if breastfeeding, one should either discontinue breastfeeding or stop taking this medication since it may be transmitted through breast milk. Safety in pediatric patients has not been established, so it is advisable not to use in children. Elderly patients may require dosage adjustments as drug metabolism may be slower. In case of overdose, symptoms such as low blood pressure or abnormal heart rhythms may occur, and immediate medical attention should be sought if such symptoms arise.

Side effects

Dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best to keep it at room temperature between 1 to 25 degrees Celsius. This will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.